Dendritic cells and tumor microenvironment: a dangerous liaison
- PMID: 16916762
- PMCID: PMC1994724
- DOI: 10.1080/08820130600803429
Dendritic cells and tumor microenvironment: a dangerous liaison
Abstract
The fact that the immune response to cancer is compromised has been convincingly demonstrated in murine tumor models as well as in cancer patients. The unresponsiveness of the host immune system is one of the major mechanisms of tumor escape as well as an important factor that limits the success of cancer immunotherapy. Inadequate function of professional antigen presenting cells dendritic cells (DC) in cancer is one of the major elements of compromised anti-tumor immune response. Despite substantial progress in recent years, the mechanism of inadequate DC function in cancer still remains unclear. The tumor microenvironment has emerged as an important component contributing to DC malfunction. In this review we will discuss the potential role of tumor microenvironment in DC dysfunction.
Similar articles
-
Tumor-host immune interactions and dendritic cell dysfunction.Adv Cancer Res. 2004;92:13-27. doi: 10.1016/S0065-230X(04)92002-7. Adv Cancer Res. 2004. PMID: 15530555 Review.
-
Tumor microenvironment-related dendritic cell deficiency: a target to enhance tumor immunotherapy.Pharmacol Res. 2020 Sep;159:104980. doi: 10.1016/j.phrs.2020.104980. Epub 2020 Jun 3. Pharmacol Res. 2020. PMID: 32504832 Review.
-
CCL21 Programs Immune Activity in Tumor Microenvironment.Adv Exp Med Biol. 2020;1231:67-78. doi: 10.1007/978-3-030-36667-4_7. Adv Exp Med Biol. 2020. PMID: 32060847 Review.
-
The roles of tumor-derived exosomes in altered differentiation, maturation and function of dendritic cells.Mol Cancer. 2021 Jun 2;20(1):83. doi: 10.1186/s12943-021-01376-w. Mol Cancer. 2021. PMID: 34078376 Free PMC article. Review.
-
Tumor-derived lactic acid modulates dendritic cell activation and antigen expression.Blood. 2006 Mar 1;107(5):2013-21. doi: 10.1182/blood-2005-05-1795. Epub 2005 Nov 8. Blood. 2006. PMID: 16278308
Cited by
-
HDACi promotes inflammatory remodeling of the tumor microenvironment to enhance epitope spreading and antitumor immunity.J Clin Invest. 2022 Oct 3;132(19):e159283. doi: 10.1172/JCI159283. J Clin Invest. 2022. PMID: 35972798 Free PMC article.
-
The impact of the immune system on tumor: angiogenesis and vascular remodeling.Front Oncol. 2014 Apr 8;4:69. doi: 10.3389/fonc.2014.00069. eCollection 2014. Front Oncol. 2014. PMID: 24782982 Free PMC article. Review.
-
Tumor Microenvironment in Breast Cancer-Updates on Therapeutic Implications and Pathologic Assessment.Cancers (Basel). 2021 Aug 23;13(16):4233. doi: 10.3390/cancers13164233. Cancers (Basel). 2021. PMID: 34439387 Free PMC article. Review.
-
Tumor associated regulatory dendritic cells.Semin Cancer Biol. 2012 Aug;22(4):298-306. doi: 10.1016/j.semcancer.2012.02.010. Epub 2012 Mar 6. Semin Cancer Biol. 2012. PMID: 22414911 Free PMC article. Review.
-
Clinical opportunities in combining immunotherapy with radiation therapy.Front Oncol. 2012 Nov 26;2:169. doi: 10.3389/fonc.2012.00169. eCollection 2012. Front Oncol. 2012. PMID: 23233905 Free PMC article.
References
-
- Ago T, Nunoi H, Ito T, Sumimoto H. Mechanism for phosphorylation-induced activation of the phagocyte NADPH oxidase protein p47(phox). Triple replacement of serines 303, 304, and 328 with aspartates disrupts the SH3 domain-mediated intramolecular interaction in p47(phox), thereby activating the oxidase. J Biol Chem. 1999;274:33644–33653. - PubMed
-
- Airola K, Fusenig NE. Differential stromal regulation of MMP-1 expression in benign and malignant keratinocytes. J Invest Dermatol. 2001;116:85–92. - PubMed
-
- Alard P, Clark SL, Kosiewicz MM. Mechanisms of tolerance induced by TGF beta-treated APC: CD4 regulatory T cells prevent the induction of the immune response possibly through a mechanism involving TGF beta. Eur J Immunol. 2004;34:1021–1030. - PubMed
-
- Allavena P, Piemonti L, Longoni D, Bernasconi S, Stoppacciaro A, Ruco L, Mantovani A. IL-10 prevents the differentiation of monocytes to dendritic cells but promotes their maturation to macrophages. Eur J Immunol. 1998;28:359–369. - PubMed
-
- Almand B, Resser JR, Lindman B, Nadaf S, Clark JI, Kwon ED, Carbone DP, Gabrilovich DI. Clinical significance of defective dendritic cell differentiation in cancer. Clin Cancer Res. 2000;6:1755–1766. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources